[1]王沈峰,金 迎,周禄荣,等.益气活血法治疗卵巢癌及对患者血清人附睾蛋白4、间皮素及肿瘤标记物的影响研究*[J].陕西中医杂志,2020,(5):646-649.[doi:DOI:10.3969/j.issn.10007369.2020.05.026]
　WANG Shenfeng,JIN Ying,ZHOU Lurong,et al.Yiqi Huoxue method in the treatment of ovarian cancer and effects on serum HE4,SMRP and tumor markers[J].,2020,(5):646-649.[doi:DOI:10.3969/j.issn.10007369.2020.05.026]
点击复制

益气活血法治疗卵巢癌及对患者血清人附睾蛋白4、间皮素及肿瘤标记物的影响研究*
分享到：

《陕西中医》杂志[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年5期
页码:
646-649
栏目:
临床研究
出版日期:
2020-05-05

文章信息/Info

Title:
Yiqi Huoxue method in the treatment of ovarian cancer and effects on serum HE4,SMRP and tumor markers
作者:
王沈峰1; 金 迎1; 周禄荣1; 宋文杰1; 张文红2△
1.辽宁中医药大学附属第二医院(沈阳 110034); 2.陕西省卫生行业学会服务中心(西安 710003)
Author(s):
WANG Shenfeng; JIN Ying; ZHOU Lurong; et al.
The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine(Shenyang 110034)
关键词:
卵巢癌;  益气活血法;  血清人附睾蛋白4;  可溶性间皮素相关肽;  肿瘤标记物
Keywords:
Ovarian cancer;  Yiqi Huoxue method;  HE4;  SMRP;  Tumor marker
分类号:
R737.31
DOI:
DOI:10.3969/j.issn.10007369.2020.05.026
文献标志码:
A
摘要:
目的:探讨益气活血法论治卵巢癌及对血清人附睾蛋白4(HE4)、可溶性间皮素相关肽(SMRP)及肿瘤标记物的影响,为其临床诊治提供参考。方法:选择85例卵巢癌患者作为研究对象,随机数字表法分为对照组(n=45)和观察组(n=40),其中对照组患者给予常规TP化疗,观察组患者在上述治疗的基础上外加益气活血法治疗。比较两组患者治疗前后的血清人附睾蛋白4(HE4)、可溶性间皮素相关肽(SMRP)以及肿瘤标记物水平变化,分析两组患者治疗前后的免疫功能以及生活质量变化。随访1年,比较两组患者治疗后的总体有效率和疾病控制率差异。结果:与治疗前相比,两组患者治疗后血清HE4、SMRP、CEA、NSE、CA19-9、CA125水平以及CD4+ CD25+、CD8+ CD28-、CD8 + CD28+水平均明显降低,且观察组患者上述指标降低更为显著(P<0.05)。观察组患者的生活质量改善率、总体有效率、疾病控制率均明显高于对照组(P<0.05)。结论:益气活血法治疗卵巢癌患者,可以明显降低其血清HE4、SMRP及肿瘤标记物水平,调节机体免疫力,提高预后生活质量,改善疾病治疗的有效率和控制率。
Abstract:
Objective:To explore the effect of Yiqi Huoxue method on ovarian cancer and its effects on serum human epididymis protein 4(HE4),soluble mesothelin-related peptide(SMRP)and tumor markers,and provide reference for its clinical diagnosis and treatment.Methods:85 cases of ovarian cancer patients were selected as the research objects.According to the random number method,they were randomly divided into the control group(n=45)and the observation group(n=40),among which the control group was given conventional TP chemotherapy,and the observation group was treated with the method of invigorating qi and activating blood circulation on the basis of the above treatment.Changes in serum human epididymal protein 4(HE4),soluble mesothelium-related peptide(SMRP)and tumor markers before and after treatment were compared between the two groups.Changes in immune function and quality of life before and after treatment were analyzed.After 1 year of follow-up,the overall efficiency and disease control rate difference between the two groups after treatment were compared.Results:Serum HE4,SMRP,CEA,NSE,CA19-9,CA125 levels,CD4+ CD25+,CD8- CD28-,CD8+ CD28-,CD8+ CD28+ levels were significantly lower in the two groups after treatment than before treatment,and the above indicators were significantly lower in the observation group(P<0.05).The improvement rate of quality of life,overall effective rate and disease control rate of patients in the observation group were significantly higher than those in the control group,with statistically significant differences(P<0.05).Conclusion:Yiqi Huoxue therapy for patients with ovarian cancer can significantly reduce the serum levels of HE4,SMRP and tumor markers,regulate the body immunity,improve the prognosis quality of life,improve the efficiency and control rate of disease treatment,and have certain clinical application value.

参考文献/References:

[1] 曾苗雨,易旦冰,陈晓亮,等.CT、MRI诊断卵巢癌价值的临床研究[J].中华临床医师杂志:电子版,2016,10(9):1275-1278.
[2] 李 宁,田永巍,高 岭,等.卵巢癌恶性腹腔积液TP方案静脉联合循环热灌注化疗临床疗效分析[J].中华肿瘤防治杂志,2017,24(2):119-123.
[3] 徐先容.黄芪桂枝五物汤加减对卵巢癌TP方案化疗引起神经毒性的防治效果[J].陕西中医,2016,37(4):396-397.
[4] 张富斌,崔李宁,徐科君.紫杉醇脂质体与传统紫杉醇联合卡铂治疗卵巢癌的疗效及不良反应的对比分析[J].中华全科医学,2017,15(5):808-810.
[5] 陈聪博,陈星余.益气活血解毒方对晚期卵巢癌患者免疫功能及生活质量的影响[J].中国老年学杂志,2017,37(13):3242-3244.
[6] 赵冰冰,阳志军,王 琪,等.多指标联合检测的液态悬浮芯片技术在卵巢恶性肿瘤诊断中的应用[J].中华妇产科杂志,2017,52(1):11-19.
[7] Nomelini RS,De LC,Tavaresmurta BM,et al.Parameters of blood count and tumor markers:a retrospective analysis and relation to prognostic factors in ovarian cancer[J].European Journal of Gynaecological Oncology,2017,38(3):364-367.
[8] 杨利娟,张 波,杨永秀.新辅助化疗与初始肿瘤细胞减灭术治疗晚期卵巢癌疗效的系统评价[J].中国实用妇科与产科杂志,2017,33(2):171-176.
[9] 南 燕,张恩娣.卵巢癌40例化疗前后血清中CA125、TNF-a和SIL-2R检测及意义[J].陕西医学杂志,2017,46(1):125-127.
[10] 闫会苓,马 丹,卢雯平.益气活血解毒方对晚期卵巢癌患者免疫调节的影响[J].中国中医药信息杂志,2016,23(1):27-30.
[11] 冯 艳,贺 晶.参麦注射液联合腹腔热灌注化疗治疗卵巢癌疗效观察[J].现代中西医结合杂志,2016,25(29):3212-3214.
[12] 郑 翔,郭 勇,李 妍.乳腺癌气虚血瘀证小鼠模型的建立及益气活血法的干预研究[J].北京中医药大学学报,2017,40(10):849-855.
[13] 李立峰,韩 猛.益气活血法辅助治疗乳腺癌术后患者的疗效及对患者生存质量的影响[J].四川中医,2015,6(3):119-121.
[14] Kreuzinger C,Geroldinger A,Smeets D,et al.A complex network of tumor microenvironment in human high grade serous ovarian cancer[J].Clinical Cancer Research An Official Journal of the American Association for Cancer Research,2017,23(24):7621-7632.
[15] Romagnolo C,Leon AE,Fabricio AS,et al.HE4,CA125 and risk of ovarian malignancy algorithm(ROMA)as diagnostic tools for ovarian cancer in patients with a pelvic mass:An Italian multicenter study[J].Gynecologic Oncology,2016,141(2):303-311.
[16] 敬 宏,牛晓宇.卵巢癌肿瘤干细胞及其标志物在卵巢癌诊疗中作用的研究进展[J].中华妇幼临床医学杂志:电子版,2017,13(2):226-230.
[17] 臧文华,唐德才.益气活血法治疗原发性肝癌的理论探讨[J].中国中医基础医学杂志,2015,21(12):1498-1500,1521.

相似文献/References:

[1]常丰葛,张 珂,马玉瑶,等.白花蛇舌草提取物对卵巢癌模型大鼠的疗效及对其血清性激素水平的影响*[J].陕西中医杂志,2019,(6):687.
　CHANG Fengge,ZHANG Ke,MA Yuyao,et al.Effect of hedyotis diffusa extract on ovarian cancer model rats and its effect on serum sex hormone levels[J].,2019,(5):687.
[2]胡天祺,杨梦琪,杨 红,等.益气养阴方对卵巢癌术后患者化疗不良反应及生存质量的影响[J].陕西中医杂志,2021,(4):434.[doi:DOI:10.3969/j.issn.1000-7369.2020.04.007]
　HU Tianqi,YANG Mengqi,YANG Hong,et al.Effect of Yiqi Yangyin recipe on the adverse reaction effects and quality of life in patients with ovarian cancer undergoing chemotherapy[J].,2021,(5):434.[doi:DOI:10.3969/j.issn.1000-7369.2020.04.007]
[3]李成斐,朱 萍,于 佳,等.益气活血解毒方联合化疗治疗晚期卵巢癌疗效及对患者免疫通路相关靶基因的影响[J].陕西中医杂志,2021,(8):1072.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.021]
　LI Chengfei,ZHU Ping,YU Jia,et al.The effect of Yiqi Huoxie Jiedu decoction combined with TC regimen on advanced ovarian cancer and related target genes of immune pathway[J].,2021,(5):1072.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.021]
[4]王小玉,韩凤娟.基于“天癸-肾阳-命门”学说探究卵巢癌发病机制[J].陕西中医杂志,2021,(9):1261.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.029]
[5]陈双凤,吉亚南.温阳活血方对卵巢癌患者免疫指标及炎性因子的影响[J].陕西中医杂志,2021,(10):1371.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.011]
[6]刘少璇,李 佳,刘芳媛,等.基于“亢害承制”理论辨析卵巢癌因机证治[J].陕西中医杂志,2022,(7):925.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.027]
　LIU Shaoxuan,LI Jia,LIU Fangyuan,et al.An analysis of mechanism in ovarian cancer based on the theory of “restraining excessiveness to acquire harmony”[J].,2022,(5):925.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.027]

备注/Memo

备注/Memo:
*辽宁省教育厅基金资助项目(L2015344)
更新日期/Last Update: 2020-05-14